Changes in Health and Functional Status in Patients With Chronic Obstructive Pulmonary Disease During Therapy With Spiolto® Respimat® (AERIAL®)
NCT03165045
·
clinicaltrials.gov ↗
COMPLETED
Status
1351
Enrollment
INDUSTRY
Sponsor class
Conditions
Pulmonary Disease, Chronic Obstructive
Interventions
DRUG:
Spiolto® Respimat®
Sponsor
Boehringer Ingelheim